U‐shaped association between pan‐immune‐inflammation value and periodontitis: NHANES 2009–2014
Journal of Periodontology · 2025
DOI: 10.1002/jper.24-0318 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Periodontology, 2025. Verfasst von Huan Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi'an Jiaotong University, Xi'an, China. Hauptthemen laut MEDLINE: Periodontitis, Inflammation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Background
This study aimed to investigate the relationship between the pan‐immune‐inflammation value (PIV) and periodontitis based on a large national survey.
Methods
In the present cross‐sectional study, data were obtained from the National Health and Nutrition Examination Survey (NHANES) 2009–2014, which included a total of 10,300 participants. The categorization of periodontitis was based on the 2017 classification scheme. The PIV was determined using the formula: (neutrophils count × monocyte count × platelet count)/lymphocytes count. Restricted cubic spline and weighted multivariable logistic regression analyses were employed to evaluate the associations between the PIV with periodontitis.
Results
The associations between PIV and stage III/IV periodontitis followed a U‐shaped pattern ( P non‐linearity < 0.001). The risk of developing stage III/IV periodontitis showed an increasing trend among participants in the first quartile (odds ratio [OR] = 1.21; 95% confidence interval [CI]: 1.01–1.46), third quartile (OR = 1.34; 95% CI: 1.11–1.61), and fourth quartile (OR = 1.47; 95% CI: 1.25–1.73) compared to those in the second quartile. Subgroup analysis indicated stronger associations of PIV with periodontitis in males (OR Q4vs2 = 1.72, 95% CI: 1.36–2.18) and individuals with hypertension (OR Q4vs2 = 1.78, 95% CI: 1.38–2.28) with significant interactions ( P interaction < 0.05).
Conclusions
There is a U‐shaped association between PIV and stage III/IV periodontitis, which suggests a potential adjunctive treatment strategy for periodontitis. Higher PIV values were found to have a stronger correlation with stage III/IV periodontitis in males and individuals with hypertension. Further prospective trials are needed to confirm the validity of our results. Plain Language Summary A U‐shaped association exists between the pan‐immune inflammation value and periodontitis in US adults, suggesting that maintaining a moderate immune inflammation response is crucial for periodontal health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi'an Jiaotong University, Xi'an, China.
- Department of Periodontology, College of Stomatology, Xi'an Jiaotong University, Xi'an, China.
- Department of Stomatology, Hunan University of Medicine, Hunan, China.
- Department of Periodontics, Liaoning Provincial Key Laboratory of Oral Diseases, School and Hospital of Stomatology, China Medical University, Shenyang, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
Zitieren
APA
Zhou, H., Zhang, S., Miao, D., & Cao, R. (2025). U‐shaped association between pan‐immune‐inflammation value and periodontitis: NHANES 2009–2014. Journal of Periodontology. https://doi.org/10.1002/jper.24-0318
Vancouver
Zhou H, Zhang S, Miao D, Cao R. U‐shaped association between pan‐immune‐inflammation value and periodontitis: NHANES 2009–2014. Journal of Periodontology. 2025. doi:10.1002/jper.24-0318
BibTeX
@article{Zhou2025,
author = {Zhou, Huan and Zhang, Shusen and Miao, Di and Cao, Ruoyan},
title = {U‐shaped association between pan‐immune‐inflammation value and periodontitis: NHANES 2009–2014},
journal = {Journal of Periodontology},
year = {2025},
doi = {10.1002/jper.24-0318}
}
EUVIMED